Sponsored by the ASHP Foundation
Application Submission Materials Available: July 14, 2014
Letter of Intent Deadline: October 3, 2014
The ASHP Research and Education Foundation (ASHP Foundation) is offering a research grant program that will support practice-based research, related to the ASHP/ASHP Foundation Pharmacy Practice Model Initiative (PPMI), conducted by pharmacist new investigators. Practice-based research affects a wide range of practice model topics, including:
• patient education
• patient outcomes and effectiveness of medication therapy
• health care quality
• medication use in minority, elderly and other special populations
• medication costs and financing
• program evaluations
• access to medications.
A secondary goal of the program is to develop new investigators’ research skills while fostering development of mentoring relationships with more experienced senior investigators.
The proposed practice-based research must be consistent with the vision, mission and strategic priorities of the ASHP Foundation. The PPMI is driven by a set of assumptions, beliefs, and recommendations from the November 2010 ASHP/ASHP Foundation PPMI Summit and the recommendations from the March 2014 ASHP Ambulatory Conference and Summit.
Submission of studies that evaluate the pharmacy practice models in hospitals, health systems, and other ambulatory settings - such as the utilization of technology, role delineation changes for the pharmacists and non-pharmacists, or improving the patient care opportunities for pharmacists–is invited. Applicants can find the recommendations from the PPMI Summit and the Ambulatory PPMI in the PPMI Web Resource Center. This resource center also includes the full proceedings of the PPMI Summit along with audio-synchronized slide presentations. Full proceedings from the Ambulatory Conference and Summit will be published in the American Journal of Health-System Pharmacy on August 15, 2014.
Applications for this research grant program should emphasize:
1) Measurable objectives that relate practice-based research that focuses on advancing pharmacy practice models.
2) Rigorous research methods that support the study objective.
3) Mentoring activities between a senior investigator/advisor and the new investigator.
4) A description of the impact that the results of the project will have on advancing pharmacy practice models.
5) A description of the potential to generalize findings to other health care facilities.
6) Interdisciplinary collaboration.
7) An organized plan for prudent use of grant funds.
Preference will be given to research projects with the potential to yield strong scientific evidence that can be used to advance pharmacy practice models.
The proposed research must focus on the advancement of pharmacy practice models and be conducted by a pharmacist new investigator. The principal investigator must be a new researcher within 5 years of completion of his/her terminal degree or postgraduate training or have professional experience greater than five years and no more than two externally funded research projects as a principal investigator. The principal investigator must be a licensed pharmacist and multidisciplinary research teams are strongly encouraged.
A senior investigator must participate on the research team as a mentor/advisor. In the application process and grant progress reports, evidence must be included regarding the support and involvement of the senior investigator. For this grant program, the senior investigator assumes responsibility for compliance with all requirements of the grant program. The senior investigator does not have to be a pharmacist. Applicants are strongly encouraged to include an individual with a strong research track record as the senior investigator. History of publication of original research in peer-reviewed biomedical journals and receipt of extramural grant funding will be used to evaluate the senior investigator’s research track record.
The proposed research must be submitted to an institutional review board (IRB) for approval. Evidence of IRB approval must be provided to the ASHP Foundation upon acceptance of the grant award. Grant funds will not be disbursed until evidence of IRB approval, or exemption from review, has been received.
The research must comply with the NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research that was amended in October 2001.
The research must comply with the NIH Policy and Guidelines on the Inclusion of Children as Participants in Research Involving Human Subjects.
The study timeline should not exceed 24 months from project initiation.
Two $20,000 grants will be awarded. Grants will be awarded to pharmacist new investigators to provide funding for specific practice-based research related to advancing pharmacy practice models in hospitals and health systems and are not intended for long-term support of research programs. Facilities and administrative cost rates that do not exceed 8 percent of the total requested budget are allowed.
Letter of Intent Submission Process and Selection Criteria
All interested applicants are required to submit a Letter of Intent to the ASHP Foundation by October 3, 2014. This Letter of Intent must be limited to a maximum of two pages (using 11-point font or larger, 8.5 x 11-inch paper, 1-inch margins, single spacing and single-sided pages) and should concisely describe the study’s specific aims and hypothesis, rationale and significance, innovation, and approach. Headings should be provided for each of these sections. View the scale used to score the Letters of Intent.
Based on the results of external peer review of Letters of Intent, applicants will be invited to submit a full grant application to the ASHP Foundation. Prior to submission of a full application, applicants will be required to participate in a webinar that describes the grant program requirements and expectations.
The full applications for the grant will be evaluated using the selection criteria listed below:
Overall Funding Priority Score = ________ (1-9)
Using the following rating scale, reviewers will provide an overall priority score to reflect their overall assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved. This score represents the reviewers overall assessment of the application and is not based only on the criteria-based score. View the scale used to score the applications
Criteria Based Score = ________ (0-100)
Using the following criteria, reviewers should provide an overall score to reflect their assessment of the study: rationale; objectives; significance and innovation; investigators and environment; study methods; and scope and timeline.
• Specific Aims and Hypothesis (20 points maximum)
• Rationale and Significance (10 points maximum)
• Innovation (10 points maximum)
• Investigators and Environment (15 point maximum)
• Approach (40 points maximum)
• Scope and Timeline (5 points maximum)
Please submit letters of intent using the electronic submission process:
• Complete the online Letter of Intent
• Read the Application Guidelines and Policies
• Watch a recording of the August 13th "How to Submit a Successful Application" webinar. (Please note that download may take approximately 30 seconds.)
• Download a PDF of the webinar slides.
• Letter of Intent Deadline: October 3, 2014
Learn more about grant recipients chosen this year and in previous years.